Application of peroral pancreatoscope in the diagnosis and treatment of pancreatic duct diseases (with video)
10.3760/cma.j.cn321463-20230711-00272
- VernacularTitle:经口胰管镜在胰管内疾病诊疗中的应用分析(含视频)
- Author:
Guosheng CHEN
1
;
Hao YUAN
;
Li ZHAO
;
Shaoqing FAN
;
Yi ZHU
;
Wentao GAO
;
Junli WU
;
Kuirong JIANG
;
Yi MIAO
;
Bin XIAO
Author Information
1. 南京医科大学第一附属医院胰腺中心，南京 210029
- Keywords:
Pancreatic intraductal neoplasms;
Peroral pancreatoscope;
Pancreatic duct diseases;
Pancreatolithiasis
- From:
Chinese Journal of Digestive Endoscopy
2023;40(11):925-929
- CountryChina
- Language:Chinese
-
Abstract:
A retrospective study was conducted on data of 23 patients with pancreatic duct diseases who were underwent peroral pancreatoscopy (POPS) at the Pancreatic Center of the First Affiliated Hospital of Nanjing Medical University from August 2020 to October 2022. The intraoperative observation, postoperative complications, and the diagnosis and treatment of POPS for pancreatic duct diseases were analyzed. All patients underwent POPS and achieved technical success. Among them, 7 patients were diagnosed as having intraductal papillary mucinous neoplasm of pancreas and 3 pancreatic malignant tumor. Eight patients with pancreatolithiasis accepted laser or eletrohydraulic lithotripsy under POPS. Abdominal pain improved in 2 patients with chronic pancreatitis after treatment. Melena disappeared in 2 patients with pancreatic duct hemorrhage or pancreatic enterostomy inflammation after conservative treatment. The symptom of 1 patient with pancreatic enterostomy stenosis improved after balloon dilation. There was no complication in the 23 patients, and the operation time was 35-90 min. The results indicate POPS is safe, effective with distinctive advantages in the diagnosis and treatment for pancreatic duct diseases.
